Recent advances in drug eluting stents

International Journal of Pharmaceutics

Volumn 441, Issue 1-2, 2013, Pages 665-679

  Puranik, Amey S ^a   Dawson, Eileen R ^a   Peppas, Nicholas A ^a,b  

^a The University of Texas at Austin   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Controlled release; Drug eluting stent; Restenosis; Sirolimus; Stent

Indexed keywords

CURCUMIN; DEXAMETHASONE; EVEROLIMUS; HEPARIN; PACLITAXEL; PIMECROLIMUS; RAPAMYCIN; TACROLIMUS; UMIROLIMUS; ZOTAROLIMUS;

ATHEROSCLEROSIS; BARE METAL STENT; BIOCOMPATIBLE STENT; BIODEGRADABLE STENT; BREAST CANCER; DRUG CARRIER ELUTING STENT; DRUG DELIVERY SYSTEM; DRUG ELUTING STENT; GENE ELUTING STENT; HUMAN; IN-STENT RESTENOSIS; LUNG CANCER; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; RESTENOSIS; REVIEW; STENT;

ANIMALS; ATHEROSCLEROSIS; CORONARY OCCLUSION; CORONARY RESTENOSIS; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; DRUG-ELUTING STENTS; HUMANS; NEOINTIMA; STENTS;

EID: 84872806047     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2012.10.029     Document Type: Review

References (110)

1. G. Acharya, and K. Park Mechanisms of controlled drug release from drug-eluting stents Adv. Drug Deliv. Rev. 58 2006 387 401
2. J. Ako, H.N. Bonneau, Y. Honda, and P.J. Fitzgerald Design criteria for the ideal drug-eluting stent Am. J. Cardiol. 100 2007 3M 9M
3. M.N. Babapulle, and M.J. Eisenberg Coated stents for the prevention of restenosis: Part I Circulation 106 2002 2734 2740
4. S. Banai, M. Chorny, S.D. Gertz, I. Fishbein, J.C. Gao, L. Perez, G. Lazarovichi, A. Gazit, A. Levitzki, and G. Golomb Locally delivered nanoencapsulated tyrphostin (AGL-2043) reduces neointima formation in balloon-injured rat carotid and stented porcine coronary arteries Biomaterials 26 2005 451 461
5. A.L. Bartorelli, D. Trabattoni, F. Fabbiocchi, P. Montorsi, S. de Martini, G. Calligaris, G. Teruzzi, S. Galli, and P. Ravagnani Synergy of passive coating and targeted drug delivery: the tacrolimus-eluting Janus CarboStent J. Interv. Cardiol. 16 2003 499 505
6. A. Baumbach, C. Herdeg, M. Kluge, M. Oberhoff, M. Lerch, K.K. Haase, C. Wolter, S. Schroder, and K.R. Karsch Local drug delivery: impact of pressure, substance characteristics, and stenting on drug transfer into the arterial wall Catheter. Cardiovasc. Interv. 47 1999 102 106
7. M.R. Bennett In-stent stenosis: pathology and implications for the development of drug eluting stents Heart 89 2003 218 224
8. J.A. Berliner, and J.W. Heinecke The role of oxidized lipoproteins in atherogenesis Free Radical Bio. Med. 20 1996 707 727
9. L. Buellesfeld, and E. Grube ABT-578-eluting stents - the promising successor of sirolimus- and paclitaxel-eluting stent concepts? Herz 29 2004 167 170
10. H.M. Burt, and W.L. Hunter Drug-eluting stents: an innovative multidisciplinary drug delivery platforms Adv. Drug Deliv. Rev. 58 2006 345 346
11. A.J. Carter, A. Brodeur, R. Collingwood, S. Ross, L. Gibson, C.A. Wang, S. Haller, L. Coleman, and R. Virmani Experimental efficacy of an everolimus eluting cobalt chromium stent Catheter. Cardiovasc. Interv. 68 2006 97 103
12. W.R. Castanedazuniga, A. Formanek, M. Tadavarthy, Z. Vlodaver, J.E. Edwards, C. Zollikofer, and K. Amplatz The mechanism of balloon angioplasty Radiology 135 1980 565 571
13. M.-C. Chen, Y. Chang, C.-T. Liu, W.-Y. Lai, S.-F. Peng, Y.-W. Hung, H.-W. Tsai, and H.-W. Sung The characteristics and in vivo suppression of neointimal formation with sirolimus-eluting polymeric stents Biomaterials 30 2009 79 88
14. M.C. Chen, H.F. Liang, Y.L. Chiu, Y. Chang, H.J. Wei, and H.W. Sung A novel drug-eluting stent spray-coated with multi-layers of collagen and sirolimus J. Control. Release 108 2005 178 189
15. A. Colombo, and E. Karvouni Biodegradable stents - fulfilling the mission and stepping away Circulation 102 2000 371 373
16. M.A. Costa, and D.I. Simon Molecular basis of restenosis and drug-eluting stents Circulation 111 2005 2257 2273
17. A. Cragg, G. Lund, J. Rysavy, F. Castaneda, W. Castanedazuniga, and K. Amplatz Non-surgical placement of arterial endoprosthesis-a new technique using nitinol wire Radiology 147 1983 261 263
18. S.D. Cushing, J.A. Berliner, A.J. Valente, M.C. Territo, M. Navab, F. Parhami, R. Gerrity, C.J. Schwartz, and A.M. Fogelman Minimally modified low-density-lipoprotein induces monocyte chemotactic protein-1 in human endothelial-cells and smooth muscle cells Proc. Natl. Acad. Sci. USA 87 1990 5134 5138
19. H.D. Danenberg, I. Fishbein, J.C. Gao, J. Monkkonen, R. Reich, I. Gati, E. Moerman, and G. Golomb Macrophage depletion by clodronate-containing liposomes reduces neointimal formation after balloon injury in rats and rabbits Circulation 106 2002 599 605
20. I. DeScheerder, K. Wang, K. Wilczek, D. Meuleman, R. VanAmsterdam, G. Vogel, J. Piessens, and F. VandeWerf Experimental study of thrombogenicity and foreign body reaction induced by heparin-coated coronary stents Circulation 95 1997 1549 1553
21. D. Deshpande, H. Devalapally, and M. Amiji Enhancement in anti-proliferative effects of paclitaxel in aortic smooth muscle cells upon co-administration with ceramide using biodegradable polymeric nanoparticles Pharm. Res. 25 2008 1936 1947
22. M.B. DeYoung, and D.A. Dichek Gene therapy for restenosis - are we ready? Circ. Res. 82 1998 306 313
23. C.T. Dotter, and M.P. Judkins Transluminal treatment of arteriosclerotic obstruction Description of a new technic and a preliminary report of its application Circulation 30 1964 654 670
24. S.G. Ellis, M. Savage, D. Fischman, D.S. Baim, M. Leon, S. Goldberg, J.W. Hirshfeld, M.W. Cleman, P.S. Teirstein, C. Walker, S. Bailey, M. Buchbinder, E.J. Topol, and R.A. Schatz Restenosis after placement of Palmaz-Schatz stents in native coronary-arteries-initial results of a multicenter experience Circulation 86 1992 1836 1844
25. P. Erne, M. Schier, and T.J. Resink The road to bioabsorbable stents: reaching clinical reality? Cardiovasc. Interv. Radiol. 29 2006 11 16
26. R. Fattori, and T. Piva Drug-eluting stents in vascular intervention Lancet 361 2003 247 249
27. D.P. Faxon, T.A. Sanborn, and C.C. Haudenschild Mechanism of angioplasty and its relation to restenosis Am. J. Cardiol. 60 1987 B5 B9
28. L.A. Feig, N.A. Peppas, C.K. Colton, K.A. Smith, and R.S. Lees The effect of angiotensin-II on in vivo albumin transport in normal rabbit aortic tissue Atherosclerosis 44 1982 307 318
29. A. Finkelstein, D. McClean, S. Kar, K. Takizawa, K. Varghese, N. Baek, K. Park, M.C. Fishbein, R. Makkar, F. Litvack, and N.L. Eigler Local drug delivery via a coronary stent with programmable release pharmacokinetics Circulation 107 2003 777 784
30. A.V. Finn, F.D. Kolodgie, J. Harnek, L.J. Guerrero, E. Acampado, K. Tefera, K. Skorija, D.K. Weber, H.K. Gold, and R. Virmani Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents Circulation 112 2005 270 278
31. J. Frostegard, J. Nilsson, A. Haegerstrand, A. Hamsten, H. Wigzell, and M. Gidlund Oxidized low-density lipoprotein induces differentiation and adhesion of human monocytes and the monocytic cell-line U937 Proc. Natl. Acad. Sci. USA 87 1990 904 908
32. S. Garg, H.J. Duckers, and P.W. Serruys Endothelial progenitor cell capture stents: will this technology find its niche in contemporary practice? Eur. Heart J. 31 2010 1032 1035
33. U. Gercken, A.J. Lansky, L. Buellesfeld, K. Desai, M. Badereldin, R. Mueller, G. Selbach, M.B. Leon, and E. Grube Results of the Jostent coronary stent graft implantation in various clinical settings: procedural and follow-up results Catheter. Cardiovasc. Interv. 56 2002 353 360
34. N. Grabow, D.P. Martin, K.-P. Schmitz, and K. Sternberg Absorbable polymer stent technologies for vascular regeneration J. Chem. Technol. Biotechnol. 85 2010 744 751
35. M. Guha, and N. Mackman The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells J. Biol. Chem. 277 2002 32124 32132
36. J. Hagemeister, F.M. Baer, R.H.G. Schwinger, and H.W. Hopp Compliance of a cobalt chromium coronary stent alloy - the COVIS trial Curr. Control. Trials Cardiovasc. Med. 6 2005 1 4
37. P.A. Hardhammar, H.M.M. vanBeusekom, H.U. Emanuelsson, S.H. Hofma, P.A. Albertsson, P.D. Verdouw, E. Boersma, P.W. Serruys, and W.J. vanderGiessen Reduction in thrombotic events with heparin-coated Palmaz-Schatz stents in normal porcine coronary arteries Circulation 93 1996 423 430
38. M. Haude, R. Erbel, H. Issa, and J. Meyer Quantitative-analysis of elastic recoil after balloon angioplasty and after intracoronary implantation of balloon-expandable Palmaz-Schatz stents J. Am. Coll. Cardiol. 21 1993 26 34
39. H. Hlawaty, A. San Juan, M.-P. Jacob, R. Vranckx, D. Letourneur, and L.J. Feldman Inhibition of MMP-2 gene expression with small interfering RNA in rabbit vascular smooth muscle cells Am. J. Physiol.-Heart Circ. Physiol. 293 2007 H3593 H3601
40. I. Iakovou, T. Schmidt, E. Bonizzoni, L. Ge, G.M. Sangiorgi, G. Stankovic, F. Airoldi, A. Chieffo, M. Montorfano, M. Carlino, I. Michev, N. Corvaja, C. Briguori, U. Gerckens, E. Grube, and A. Colombo Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents JAMA 293 2005 2126 2130
41. I. Iakovou, T. Schmidt, L. Ge, G.M. Sangiorgi, G. Stankovic, F. Airoldi, A. Chieffo, M. Montorfano, M. Carlino, I. Michev, N. Corvaja, J. Cosgrave, U. Gerckens, E. Grube, and A. Colombo Angiographic patterns of restenosis after paclitaxel-eluting stent implantation J. Am. Coll. Cardiol. 45 2005 805-796
42. L. Indolfi, F. Causa, C. Giovino, F. Ungaro, F. Quaglia, and P.A. Netti Microsphere-integrated drug-eluting stents: PLGA microsphere integration in hydrogel coating for local and prolonged delivery of hydrophilic antirestenosis agents J. Biomed. Mater. Res. Part A 97A 2011 201 211
43. T. Ishida, and K. Tanaka Effects of fibrin and fibrinogen-degradation products on the growth of rabbit aortic smooth-muscle cells in culture Atherosclerosis 44 1982 161 174
44. T.W. Johnson, Y.X. Wu, C. Herdeg, A. Baumbach, A.C. Newby, K.R. Karsch, and M. Oberhoff Stent-based delivery of tissue inhibitor of metalloproteinase-3 adenovirus inhibits neointimal formation in porcine coronary arteries Arterioscler. Thromb. Vasc. Biol. 25 2005 754 759
45. M. Joner, A.V. Finn, A. Farb, E.K. Mont, F.D. Kolodgie, E. Ladich, R. Kutys, K. Skorija, H.K. Gold, and R. Virmani Pathology of drug-eluting stents in humans - delayed healing and late thrombotic risk J. Am. Coll. Cardiol. 48 2006 193 202
46. M. Joner, K. Morimoto, H. Kasukawa, K. Steigerwald, S. Merl, G. Nakazawa, M.C. John, A.V. Finn, E. Acampado, F.D. Kolodgie, H.K. Gold, and R. Virmani Site-specific targeting of nanoparticle prednisolone reduces in-stent restenosis in a rabbit model of established atheroma Arterioscler. Thromb. Vasc. Biol. 28 2008 1960-U1113
47. J.-R. Joo, H.Y. Nam, S.H. Nam, I. Baek, and J.-S. Park A novel deposition method of PLGA nanoparticles on coronary stents Bull. Korean Chem. Soc. 30 2009 1085 1087
48. H.I. Kim, M. Takai, T. Konno, R. Matsuno, and K. Ishihara Biodegradable polymer films for releasing nanovehicles containing sirolimus Drug Deliv. 16 2009 183 188
49. S.B. King A US perspective on the shortcomings of PTCA Heart 78 1997 6-6
50. B.D. Klugherz, P.L. Jones, X.M. Cui, W.L. Chen, N.F. Meneveau, S. DeFelice, J. Connolly, R.L. Wilensky, and R.J. Levy Gene delivery from a DNA controlled-release stent in porcine coronary arteries Nat. Biotechnol. 18 2000 1181 1184
51. K. Kolandaivelu, R. Swaminathan, W.J. Gibson, V.B. Kolachalama, K. Nguyen-Ehrenreich, V.L. Giddings, L. Coleman, G.K. Wong, and E.R. Edelman Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings Circulation 123 2011 1400 1409
52. M.W. Krucoff, D.J. Kereiakes, J.L. Petersen, R. Mehran, V. Hasselblad, A.J. Lansky, P.J. Fitzgerald, J. Garg, M.A. Turco, C.A. Simonton III, S. Verheye, C.L. Dubois, R. Gammon, W.B. Batchelor, C.D. O'Shaughnessy, J.B. Hermiller Jr., J. Schofer, M. Buchbinder, W. Wijns, and C.I.I. Grp A novel bioresorbable polymer paclitaxel- eluting stent for the treatment of single and multivessel coronary disease J. Am. Coll. Cardiol. 51 2008 1543 1552
53. N. Kukreja, Y. Onuma, J. Daemen, and P.W. Serruys The future of drug-eluting stents Pharmacol. Res. 57 2008 171 180
54. C.J. Kuo, J.K. Chung, D.F. Fiorentino, W.M. Flanagan, J. Blenis, and G.R. Crabtree Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase Nature 358 1992 70 73
55. D.M. Liu, T. Troczynski, and W.J. Tseng Water-based sol-gel synthesis of hydroxyapatite: process development Biomaterials 22 2001 1721 1730
56. D.M. Liu, Q.Z. Yang, and T. Troczynski Sol-gel hydroxyapatite coatings on stainless steel substrates Biomaterials 23 2002 691 698
57. H.C. Lowe, S.N. Oesterle, and L.M. Khachigian Coronary in-stent restenosis: current status and future strategies J. Am. Coll. Cardiol. 39 2002 183 193
58. T.F. Luescher, J. Steffel, F.R. Eberli, M. Joner, G. Nakazawa, F.C. Tanner, and R. Virmani Drug-eluting stent and coronary thrombosis - biological mechanisms and clinical implications Circulation 115 2007 1051 1058
59. C. Luo, Y. Zheng, Z. Diao, J. Qiu, and G. Wang Review: research progress and future prospects for promoting endothelialization on endovascular stents and preventing restenosis J. Med. Biol. Eng. 31 2011 307 316
60. S.O. Marx, H. Totary-Jain, and A.R. Marks Vascular smooth muscle cell proliferation in restenosis Circ. Cardiovasc. Interv. 4 2011 104 111
61. T.A. Massaro, C.E. Glatz, N.A. Peppas, G.M. Chisolm, and C.K. Colton Distribution of glycosaminoglycans in consecutive layers of the rabbit aorta Artery 5 1979 1 13
62. E.P. McFadden, E. Stabile, E. Regar, E. Cheneau, A.T.L. Ong, T. Kinnaird, W.O. Suddath, N.J. Weissman, R. Torguson, K.M. Kent, A.D. Pichard, L.F. Satler, R. Waksman, and P.W. Serruys Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy Lancet 364 2004 1519 1521
63. M. Murali, and S.H. Yeo Rapid biocompatible micro device fabrication by micro electro-discharge machining Biomed. Microdevices 6 2004 41 45
64. S. Muthukkumar, T.M. Ramesh, and S. Bondada Rapamycin, a potent immunosuppressive drug, causes programmed cell death in B lymphoma cells Transplantation 60 1995 264 270
65. M. Naito, C.M. Stirk, E.B. Smith, and W.D. Thompson Smooth muscle cell outgrowth stimulated by fibrin degradation products: the potential role of fibrin fragment E in restenosis and atherogenesis Thromb. Res. 98 2000 165 174
66. K. Nakano, K. Egashira, S. Masuda, K. Funakoshi, G. Zhao, S. Kimura, T. Matoba, K. Sueishi, Y. Endo, Y. Kawashima, K. Hara, H. Tsujimoto, R. Tominaga, and K. Sunagawa Formulation of nanoparticle-eluting stents by a cationic electrodeposition coating technology efficient nano-drug delivery via bioabsorbable polymeric nanoparticle-eluting stents in porcine coronary arteries J. Am. Coll. Cardiol. Intv. 2 2009 277 283
67. G. Nakazawa Stent thrombosis of drug eluting stent: pathological perspective J. Cardiol. 58 2011 84 91
68. G. Nakazawa, A.V. Finn, M. Vorpahl, E.R. Ladich, F.D. Kolodgie, and R. Virmani Coronary responses and differential mechanisms of late stent thrombosis attributed to first-generation sirolimus- and paclitaxel-eluting stents J. Am. Coll. Cardiol. 57 2011 390 398
69. S.H. Nam, H.Y. Nam, J.R. Joo, I.S. Back, and J.-S. Park Curcumin-loaded PLGA nanoparticles coating onto metal stent by electrophoretic deposition techniques Bull. Korean Chem. Soc. 28 2007 397 402
70. A. Nolte, T. Walker, M. Schneider, O. Kray, M. Avci-Adali, G. Ziemer, and H.P. Wendel Small-interfering RNA-eluting surfaces as a novel concept for intravascular local gene silencing Mol. Med. 17 2011 1213 1222
71. M. Ostojic, D. Sagic, R. Jung, Y.-L. Zhang, M. Nedeljkovic, L. Mangovski, S. Stojkovic, D. Debeljacki, M. Colic, B. Beleslin, B. Milosavljevic, D. Orlic, D. Topic, N. Karanovic, D. Paunovic, U. Christians, and N.P.K.I. Behalf The pharmacokinetics of biolimus A9 after elution from the nobori stent in patients with coronary artery disease: the NOBORI PK study Catheter. Cardiovasc. Interv. 72 2008 901 908
72. J.C. Palmaz, R.R. Sibbitt, S.R. Reuter, F.O. Tio, and W.J. Rice Expandable intraluminal graft-a preliminary study-work in progress Radiology 156 1985 73 77
73. D.-W. Park, S.-W. Park, K.-H. Park, B.-K. Lee, Y.-H. Kim, C.W. Lee, M.-K. Hong, J.-J. Kim, and S.-J. Park Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up Am. J. Cardiol. 98 2006 352 356
74. P. Peng, N.H. Voelcker, S. Kumar, and H.J. Griesser Nanoscale eluting coatings based on alginate/chitosan hydrogels Biointerphases 2 2007 95 104
75. S. Ramcharitar, G. Louise, J. Daemen, and P. Serruys MDrug-eluting stents, restenosis and revascularization Herz 32 2007 287 295
76. A. Raval, J. Parikh, and C. Engineer Mechanism and in vitro release kinetic study of sirolimus from a biodegradable polymeric matrix coated cardiovascular stent Ind. Eng. Chem. Res. 50 2011 9539 9549
77. M.L. Reed, C. Wu, J. Kneller, S. Watkins, D.A. Vorp, A. Nadeem, L.E. Weiss, K. Rebello, M. Mescher, A.J.C. Smith, W. Rosenblum, and M.D. Feldman Micromechanical devices for intravascular drug delivery J. Pharm. Sci. 87 1998 1387 1394
78. C.D.K. Rogers Drug-eluting stents: clinical perspectives on drug and design differences Rev. Cardiovasc. Med. 6 2005 S3 S12
79. R. Ross The pathogenesis of atherosclerosis-a perspective for the 1990 Nature 362 1993 801 809
80. R. Ross Cell biology of atherosclerosis Annu. Rev. Physiol. 57 1995 791 804
81. H. Rousseau, J. Puel, F. Joffre, U. Sigwart, C. Duboucher, C. Imbert, C. Knight, L. Kropf, and H. Wallsten Self-expanding endovascular prosthesis - an experimental-study Radiology 164 1987 709 714
82. S. Saito New horizon of bioabsorbable stent Catheter. Cardiovasc. Interv. 66 2005 595 596
83. A. San Juan, M. Bala, H. Hlawaty, P. Portes, R. Vranckx, L.J. Feldman, and D. Letourneur Development of a functionalized polymer for stent coating in the arterial delivery of small interfering RNA Biomacromolecules 10 2009 3074 3080
84. F.S. Santiago, and L.M. Khachigian Nucleic acid based strategies as potential therapeutic tools: mechanistic considerations and implications to restenosis J. Mol. Med. (Berlin) 79 2001 695 706
85. S. Satzl, C. Henn, P. Christoph, P. Kurz, U. Stampfl, S. Stampfl, F. Thomas, B. Radeleff, I. Berger, M. Grunze, and G.M. Richter The efficacy of nanoscale poly bis(trifluoroethoxy)phosphazene (PTFEP) coatings in reducing thrombogenicity and late in-stent stenosis in a porcine coronary artery model Investig. Radiol. 42 2007 303 311
86. P.B. Schiff, J. Fant, and S.B. Horwitz Promotion of microtubule assembly in vitro by taxol Nature 277 1979 665 667
87. P.W. Serruys, P. Dejaegere, F. Kiemeneij, C. Macaya, W. Rutsch, G. Heyndrickx, H. Emanuelsson, J. Marco, V. Legrand, P. Materne, J. Belardi, U. Sigwart, A. Colombo, J.J. Goy, P. Vandenheuvel, J. Delcan, and M.A. Morel A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary-artery disease New Engl. J. Med. 331 1994 489 495
88. P.W. Serruys, B. van Hout, H. Bonnier, V. Legrand, E. Garcia, C. Macaya, E. Sousa, W. van der Giessen, A. Colombo, R. Seabra-Gomes, F. Kiemeneij, P. Ruygrok, J. Ormiston, H. Emanuelsson, J. Fajadet, M. Haude, S. Klugmann, M.A. Morel, and G. Benestent Study Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II) Lancet 352 1998 673 681
89. F. Sharif, S.O. Hynes, K.J.A. McCullagh, S. Ganley, U. Greiser, P. McHugh, J. Crowley, F. Barry, and T. O'Brien Gene-eluting stents: non-viral, liposome-based gene delivery of eNOS to the blood vessel wall in vivo results in enhanced endothelialization but does not reduce restenosis in a hypercholesterolemic model Gene Ther. 19 2012 321 328
90. F. Sharif, S.O. Hynes, J. McMahon, R. Cooney, S. Conroy, P. Dockery, G. Duffy, K. Daly, J. Crowley, J.S. Bartlett, and T. O'Brien Gene-eluting stents: comparison of adenoviral and adeno-associated viral gene delivery to the blood vessel wall in vivo Hum. Gene Ther. 17 2006 741 750
91. M.H. Sketch, M. Ball, B. Rutherford, J.J. Popma, C. Russell, D.J. Kereiakes, and I. Driver Evaluation of the medtronic (Driver) cobalt-chromium alloy coronary stent system Am. J. Cardiol. 95 2005 8 12
92. H.C. Stary, A.B. Chandler, S. Glagov, J.R. Guyton, W. Insull, M.E. Rosenfeld, S.A. Schaffer, C.J. Schwartz, W.D. Wagner, and R.W. Wissler A definition of initial of fatty streak, and intermediate lesions of atherosclerosis-a report from the committee on vascular-lesions of the council on arteriosclerosis Am.-Heart Assoc. Circ. 89 1994 2462 2478
93. J. Steffel, T.F. Luscher, and F.C. Tanner Tissue factor in cardiovascular diseases - molecular mechanisms and clinical implications Circulation 113 2006 722 731
94. G. Sydow-Plum, and M. Tabrizian Review of stent coating strategies: clinical insights Mater. Sci. Technol. 24 2008 1127 1143
95. N. Tada, R. Virmani, G. Grant, L. Bartlett, A. Black, C. Clavijo, U. Christians, R. Betts, D. Savage, S.-H. Su, J. Shulze, and S. Kar Polymer-free biolimus A9-coated stent demonstrates more sustained intimal inhibition, improved healing, and reduced inflammation compared with a polymer-coated sirolimus-eluting cypher stent in a porcine model Circ. Cardiovasc. Interv. 3 2010 174 183
96. K. Takahata, and Y.B. Gianchandani A planar approach for manufacturing cardiac stents: design, fabrication, and mechanical evaluation J. Microelectromechan. Syst. 13 2004 933 939
97. S. Tanimoto, P.W. Serruys, L. Thuesen, D. Dudek, B. de Bruyne, B. Chevalier, and J.A. Ormiston Comparison of in vivo acute stent recoil between the bioabsorbable everolimus-eluting coronary stent and the everolimus-eluting cobalt chromium coronary stent: insights from the ABSORB and SPIRIT trials Catheter. Cardiovasc. Interv. 70 2007 515 523
98. N. Terada, J.J. Lucas, A. Szepesi, R.A. Franklin, K. Takase, and E.W. Gelfand Rapamycin inhibits the phosphorylation of p70 S6 kinase in IL-2 and mitogen-activated human T-cells Biochem. Biophys. Res. Commun. 186 1992 1315 1321
99. B.L. Van der Hoeven, N.M. Pires, H.M. Warda, P.V. Oemrawsingh, B.J. van Vlijmen, P.H. Quax, M.J. Schalij, E.E. van der Wall, and J.W. Jukema Drug-eluting stents: results, promises and problems Int. J. Cardiol. 99 2005 9 17
100. J. Varshosaz, and M. Soheili Production and in vitro characterization of lisinopril-loaded nanoparticles for the treatment of restenosis in stented coronary arteries J. Microencapsul. 25 2008 478 486
101. E.M. Vasquez Sirolimus: a new agent for prevention of renal allograft rejection Am. J. Health Syst. Pharm. 57 2000 437 448
102. S. Verheye, W. Martinet, M.M. Kockx, M.W.M. Knaapen, K. Salu, J.-P. Timmermans, J.T. Ellis, D.L. Kilpatrick, and G.R.Y. De Meyer Selective clearance of macrophages in atherosclerotic plaques by autophagy J. Am. Coll. Cardiol. 49 2007 706 715
103. R. Virmani, G. Guagliumi, A. Farb, G. Musumeci, N. Grieco, T. Motta, L. Mihalcsik, M. Tespili, O. Valsecchi, and F.D. Kolodgie Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent should we be cautious? Circulation 109 2004 701 705
104. M.C.M. Vrolix, V.M. Legrand, J.H.C. Reiber, G. Grollier, M.J. Schalij, P. Brunel, L. Martinez-Elbal, M. Gomez-Recio, F. Bar, M.E. Bertrand, A. Colombo, J. Brachman, and M.T. Investigators Heparin-coated Wiktor stents in human coronary arteries (MENTOR trial) Am. J. Cardiol. 86 2000 385 389
105. D.H. Walter, M. Cejna, L. Diaz-Sandoval, S. Willis, L. Kirkwood, P.W. Stratford, A.B. Tietz, R. Kirchmair, M. Silver, C. Curry, A. Wecker, Y.S. Yoon, R. Heidenreich, A. Hanley, M. Kearney, F.O. Tio, P. Kuenzler, J.M. Isner, and D.W. Losordo Local gene transfer of phVEGF-2 plasmid by gene-eluting stents - an alternative strategy for inhibition of restenosis Circulation 110 2004 36 45
106. X. Wang, S.S. Venkatraman, F.Y.C. Boey, J.S.C. Loo, and L.P. Tan Controlled release of sirolimus from a multilayered PLGA stent matrix Biomaterials 27 2006 5588 5595
107. Wani, M.C., Taylor, H.L., Wall, M.E., Coggon, P., McPhail, A.T., 1971. Plant antitumor agents 6. Isolation and structure of Taxol, a novel antileukemic and antitumor agent from taxus brevifolia. J. Am. Chem. Soc. 93, 2325.
108. F.G.P. Welt, and C. Rogers Inflammation and restenosis in the stent era Arterioscler. Thromb. Vasc. Biol. 22 2002 1769 1776
109. G.J. Wilson, G. Nakazawa, R.S. Schwartz, B. Huibregtse, B. Poff, T.J. Herbst, D.S. Baim, and R. Virmani Comparison of inflammatory response after implantation of sirolimus- and paclitaxel-eluting stents in porcine coronary arteries Circulation 120 2009 U141 U175
110. Y.W. Ye, C. Landau, J.E. Willard, G. Rajasubramanian, A. Moskowitz, S. Aziz, R.S. Meidell, and R.C. Eberhart Bioresorbable microporous stents deliver recombinant adenovirus gene transfer vectors to the arterial wall Ann. Biomed. Eng. 26 1998 398 408